Manipulating myosin to curb cardiomyopathy
Hypertrophic cardiomyopathy (HCM, thickened heart muscle) is a disease typically caused by mutations in sarcomere genes. Sarcomeres are the functional and structural units in muscle that allow for contraction and relaxation. Toepfer et al. investigated how mutations in cardiac myosin-binding protein C (encoded by MYBPC3) alter cardiac muscle contraction and relaxation. Using mouse models and human muscle fibers, they showed that MYBPC3 mutations increased contractility and decreased relaxation by disrupting myosin conformations. Treating cardiomyocytes with a myosin allosteric inhibitor corrected the relaxation, contraction, and myosin conformation deficits, suggesting that the myosin inhibitor could be therapeutic for HCM.
- Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works
This is an article distributed under the terms of the Science Journals Default License.